Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jul;338(1):280-9.
doi: 10.1124/jpet.111.179705. Epub 2011 Apr 7.

Abuse liability profile of three substituted tryptamines

Affiliations
Comparative Study

Abuse liability profile of three substituted tryptamines

Michael B Gatch et al. J Pharmacol Exp Ther. 2011 Jul.

Abstract

The abuse liability profile of three synthetic hallucinogens, N,N-diisopropyltryptamine (DIPT), 5-N,N-diethyl-5-methoxytryptamine (5-MeO-DET), and 5-methoxy-α-methyltryptamine (5-MeO-AMT), was tested in rats trained to discriminate hallucinogenic and psychostimulant compounds, including cocaine, methamphetamine, 3,4-methylenedioxymethylamphetamine (MDMA), lysergic acid diethylamide (LSD), (-)-2,5-dimethoxy-4-methylamphetamine (DOM), and dimethyltryptamine (DMT). Because abused hallucinogens act at 5-hydroxytryptamine 1A (5-HT(1A)) and 5-HT(2A) receptors, and abused psychostimulants act at monoamine transporters, binding and functional activities of DIPT, 5-MeO-DET, and 5-MeO-AMT at these sites were also tested. DIPT fully substituted in rats trained to discriminate DMT (ED(50) = 1.71 mg/kg) and DOM (ED(50) = 1.94 mg/kg), but produced only 68% LSD-appropriate responding. 5-MeO-DET fully substituted for DMT (ED(50) = 0.41 mg/kg) and produced 59% MDMA-appropriate responding. 5-MeO-AMT did not fully substitute for any of the training drugs, but produced 67% LSD-appropriate responding. None of the compounds produced substitution in rats trained to discriminate cocaine or methamphetamine. All three compounds showed activity at 5-HT(1A) and 5-HT(2A) receptors as well as blockade of reuptake by the serotonin transporter. In addition, 5-MeO-AMT produced low levels of serotonin release and low potency blockade of dopamine uptake. DIPT, 5-MeO-DET, and 5-MeO-AMT produced behavioral and receptor effects similar to those of abused hallucinogens, but were not similar to those of psychostimulants. DIPT and 5-MeO-DET may have abuse liability similar to known hallucinogens and may be hazardous because high doses produced activity and lethality.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Discriminative stimulus effects of DIPT, 5-MeO-DET, and 5-MeO-AMT in separate groups of rats trained to discriminate DMT, LSD, DOM, MDMA, cocaine, or methamphetamine from saline. Top of each pair, drug-appropriate responding of the test compounds in DMT-, LSD-, DOM-, MDMA-, cocaine-, and methamphetamine-trained rats. Bottom of each pair, rate of responding in responses per second. Each point represents the average of six rats except where indicated.
Fig. 2.
Fig. 2.
Effect of DIPT, 5-MeO-DET, and 5-MeO-AMT on horizontal activity counts/10 min as a function of dose (top to bottom) and time interval during an 8-h session. Each panel shows one dose group compared with vehicle control. *, p < 0.05 compared with vehicle for depressant or stimulant effect (10–40 min).

Similar articles

Cited by

References

    1. Adkins EM, Barker EL, Blakely RD. (2001) Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition. Mol Pharmacol 59:514–523 - PubMed
    1. Cheng Y, Prusoff WH. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108 - PubMed
    1. Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE. (2009) Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm 116:1591–1599 - PubMed
    1. Deneau G, Yanagita T, Seevers MH. (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16:30–48 - PubMed
    1. Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, Janowsky A. (1999) Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J Pharmacol Exp Ther 289:877–885 - PubMed

Publication types

MeSH terms